NVAX · Novavax, Inc.
11.26
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$2.10B
PE
N/A
EV/EBITDA
N/A
DIV Yield
N/A
Payout Ratio
N/A
MQV Rating
5Very Weak
As at 16/10/2026 04:00:00 PM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- Big Candle (Realtime)
- HALO All
- HALO Price Momentum
- Hammer Bullish
- Recent Earnings upgrade
- Recent Price upgrade
- Volume Spike
Key Fundamentals
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Performance
52 weeks range
N/A
Trade Value (12mth)
N/A
1 week
%
1 month
%
YTD
%
1 year
%
All time high
N/A
Additional Data
Shares Outstanding (Fully Diluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
N/A
Short Sell (% of issue)
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
06 August 26EDG | |
06 August 26EDG | |
06 August 26EDG | |
06 August 26EDG | |
23 June 26EDG |
Key Stakeholders
| Name | Title |
| Sanofi | Public Company |
| John C.s Jacobs | Individual |
| Elaine O'Hara | Individual |
| James Patrick Kelly | Individual |
| Himanshu Harshad Shah | Individual |
